Flexion Therapeutics, Inc. IPO Research Information

Flexion Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Flexion Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Flexion Therapeutics, Inc.	FLXN - NASDAQ	$12.00-$14.00	$13.00	$16.00	5 million	2/12/2014
Underwriter(s): BMO Capital Markets, Wells Fargo Securities
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2014-01-08

Flexion Therapeutics, Inc. Quote & Chart - Click for current quote - FLXN

About Flexion Therapeutics, Inc. (adapted from Flexion Therapeutics, Inc. prospectus):
They are a specialty pharmaceutical company focused on the development and commercialization of novel, long-acting, injectable pain therapies.

This description is adapted from Flexion FLXN prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Flexion FLXN "FLXN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.